上海交通大学学报（医学版）

›› 2009, Vol. 29 ›› Issue (10): 1251-.

• 综述 • 上一篇    下一篇

病理性近视伴脉络膜新生血管的特点及其抗VEGF药物治疗

王丽娜, 综述；张 琦, 赵培泉, 审校   

  1. 上海交通大学 医学院新华医院眼科, 上海 200092
  • 出版日期:2009-10-25 发布日期:2009-10-26
  • 通讯作者: 赵培泉, 电子信箱: zhaopeiquan@126.com。
  • 作者简介:王丽娜(1985—), 女, 03级临床七年制学生；电子信箱: babywanglina@yahoo.com.cn。

Characteristics of choroidal neovascularization secondary to pathologic myopia and anti-VEGF therapy

WANG Li-na, reviewer；ZHANG Qi, ZHAO Pei-quan, reviser   

  1. Department of Ophthalmology, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200092, China
  • Online:2009-10-25 Published:2009-10-26

PDF (PC)

1520

摘要：

脉络膜新生血管是病理性近视患者常见的视力下降的重要原因之一，常引起不可逆的中心视力丧失。该文主要对病理性近视的流行病学、继发于病理性近视的脉络膜新生血管的病理机制、临床表现及其抗VEGF药物的治疗进行综述。

关键词: 病理性近视, 脉络膜新生血管, 抗VEGF治疗

Abstract:

Choroidal neovascularization is one of the common causes resulting in vision loss in patients with pathologic myopia, and the irreversible central vision loss is often found. This article reviews the epidemiology of pathologic myopia, pathogenesis, clinical manifestation and anti-VEGF therapy of choroidal neovascularization secondary to pathologic myopia.

Key words: pathologic myopia, choroidal neovascularization, anti-VEGF therapy

中图分类号: